| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.0M | +7.4% | -16.5% |
| Cost of Revenue | $6.7M | -0.2% | -21.2% |
| Gross Profit | $7.4M | +15.4% | -11.7% |
| R&D Expense | $3.8M | -12.9% | -43.5% |
| SG&A Expense | $9.1M | -11.6% | -31.7% |
| Operating Income | -$16.3M | -7.7% | +46.0% |
| Pre-tax Income | -$14.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.8M | +1.7% | +39.5% |
| Short-term Investments | $49.3M | -13.3% | +84.7% |
| Accounts Receivable | $11.0M | +77.2% | -34.0% |
| Inventory | $15.3M | -0.9% | -14.1% |
| Current Assets | $144.9M | -2.0% | +33.1% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.0M | — | — |
| Capital Expenditures | $961K | — | — |
| Investing Cash Flow | $43.9M | — | — |
| Financing Cash Flow | -$283K | — | — |
| Free Cash Flow | -$26.0M | — | — |
| -15.9% |
| +49.3% |
| Income Tax | $29K | -59.2% | +140.3% |
| Net Income | -$15.0M | -12.6% | +48.9% |
| EPS (Basic) | -$0.41 | -10.8% | +51.2% |
| EPS (Diluted) | -$0.41 | -10.8% | +51.2% |
| $190.9M |
| -0.4% |
| +7.1% |
| Current Liabilities | $41.5M | +39.6% | +61.3% |
| Total Liabilities | $54.6M | +27.3% | +15.5% |
| Stockholders' Equity | $136.3M | -8.4% | +4.0% |